In vivo, after antigenic stimulation, mice develop antibody responses representing all five major immunoglobulin classes (1-5). Evaluation of serum antibody responses to heterologous erythrocytes at the cellular level is possible with the hemolytic plaque technique which facilitates the screening of large numbers of lymphoid cells for those cells releasing antibodies against erythrocyte antigens. The technique as described initially by Jerne et al. (6, 7) enumerated only cells releasing high hemolytic efficiency, %,M antibodies (6-9). Modifications have permitted enumeration of those cells releasing antibodies of other immunoglobulin classes (10-12). By using heterologous anti-mouse globulins monospecific for each major immunoglobulin class, antibody-releasing cells from each class have been detected and the kinetics of their appearance after immunization have been described (1, 2, 5). 7G I plaque-forming cells (PFC) usually are detected later and reach maximum numbers later than do 7M PFC (1, 2, 5). "),M PFC are thought to develop by rapid division of precursor cells restricted to production of antibody of the 7M class (6, (13) (14) (15) (16) (17) .
(Received for publication 8 April 1971) In vivo, after antigenic stimulation, mice develop antibody responses representing all five major immunoglobulin classes (1) (2) (3) (4) (5) . Evaluation of serum antibody responses to heterologous erythrocytes at the cellular level is possible with the hemolytic plaque technique which facilitates the screening of large numbers of lymphoid cells for those cells releasing antibodies against erythrocyte antigens. The technique as described initially by Jerne et al. (6, 7) enumerated only cells releasing high hemolytic efficiency, %,M antibodies (6) (7) (8) (9) . Modifications have permitted enumeration of those cells releasing antibodies of other immunoglobulin classes (10) (11) (12) . By using heterologous anti-mouse globulins monospecific for each major immunoglobulin class, antibody-releasing cells from each class have been detected and the kinetics of their appearance after immunization have been described (1, 2, 5) . 7G I plaque-forming cells (PFC) usually are detected later and reach maximum numbers later than do 7M PFC (1, 2, 5) . "),M PFC are thought to develop by rapid division of precursor cells restricted to production of antibody of the 7M class (6, (13) (14) (15) (16) (17) . The developmental pathway of ~,G PFC has still not been precisely defined. These cells may arise by proliferation of specific precursors restricted to production of antibodies of a single immunoglobulin class (2, 18, 19) , or they may develop by conversion of cells from %,M to a given class of 7G antibody syn-thesis (20) .
•G PFC may also develop by recruitment of potential antibodyproducing cells restricted to immunoglobulin class without cell division (1) .
The cell suspension system for stimulation of antibody production to heterologous erythrocytes by murine spleen cells in vitro, as developed by Mishell and Dutton (21) , is ideally suited for investigation of these possibilities. Here, critical variables such as antigen presentation and interactions among required cell types can be more precisely controlled and the essential events in the development of responses representing individual immunoglobulin classes analyzed. However, in previous studies with this culture system, numerically significant primary 3'G PFC responses were not detected (22) .
The present studies were initiated to investigate whether this failure was the result of methodology and reagents or a more fundamental failure of the culture system to support development of primary "FG and ~,A PFC responses. We now present a modification of the hemolytic plaque assay which has enabled us for the first time to directly enumerate PFC representing all the major immunoglobulin classes in cultures of mouse spleen cells stimulated in vitro with heterologous erythrocytes. The culture conditions found to support development of these responses and the kinetics of appearance of PFC representing each immunoglobulin class will be described. The analysis of the effects of anti-erythrocyte antibody on primary 7M and ~/G PFC responses will illustrate some of the fundamental differences in these responses.
Materials and Methods
Animals.--C57BL/6N and BALB/cAnN male mice, 3-4 months old, and New Zealand white male rabbits, 3-6 months old, obtained from the NIH Rodent and Rabbit Production Section were maintained on the appropriate Purina chow and water ad libitum. Goats were maintained at the NIH Ungulate Division on a standard goat diet.
Erythrocyte Antigens and Anti-Erythrocyte Antisera.--Erythrocytes from one sheep (SRBC) and one horse (HRBC), maintained at the NIH Ungulate Division, were collected biweekly under sterile conditions into acid citrate-dextrose solution. Erythrocytes were washed by centrifugation three times with 40 volumes of sterile Hanks' balanced salt solution (HBSS) and resuspended in HBSS to 20 X l0 s erythrocytes/ml for immunization or for use in the hemolytic plaque assay; erythrocytes for stimulation of cultures were resuspended in HBSS to 2.5 X 10 s erythrocytes/ml. Antisera against SRBC and HRBC were obtained from rabbits bled by cardiac puncture 10 days after the last of three weekly intravenous injections of 5 ml of a suspension containing 20 )< 108 RBC/ml. Sera were separated, decomplemented by heat at 56°C for 30 min, sterilized by passage through a prewashed 0.22 # Millipore filter, and stored at --20°C in 1 ml portions. Hemagglutinin titers were 1/6000 to 1/8000 against the immunizing erythrocyte and less than 1/10 against nonimmunizing erythrocytes. Antibody activity was resistant to treatment with 0.1 M 2-mercaptoethanol for 30 min at 37°C. Antibody concentration is expressed as the reciprocal of the titer in the culture dish. For example, a serum with a titer of 1/8000 was diluted 1/1000 and 0.05 ml was added to a 1 ml culture giving a concentration of 4 >( 10 -1.
Preparation of Mydoma Proteins and Anti-Immunoglobulin Sera.--Purifled myeloma proteins were prepared from ascitic fluid from BALB/cAnN mice bearing plasma cell tumors adapted to the ascites form. Pools of urine from mice bearing myeloma tumor MOPC-104E were the source of k-chain. Immunogens for preparation of polyvalent anti-3,G and anti-3,2a -b 2b were purified from pools of hyperimmune sera from several inbred strains of mice. Immunogens were purified by preparative electrophoresis in a Geon-Pevikon resin block (23) followed by gel filtration through Sephadex-G-200 (22, 23) . Fc fragment was isolated from MOPC-31c myeloma protein after papain digestion for the preparation of anti-3,1 sera (24, 25) . Antiglobulins used for development of 3"G and 3"A PFC were prepared in rabbits using the immunogens prepared as described above and listed in Table I . Anti-mouse D-chain antibody was prepared in goats. 3"A * Germfree serum was used to absorb antibodies to serum proteins other than immunoglobulins.
All separated rabbit and goat sera were decomplemented at 56°C for 30 min and absorbed twice with 1 ml each of washed, packed SRBC and HRBC/10 ml serum and once with 1 ml of washed, packed C57BL/6N spleen cells/10 ml serum. Initial specificity of the antiglobulins was tested by double diffusion in agar. Required absorptions to achieve monospecific antiglobulins were performed using the purified myeloma proteins and germfree serum as indicated in Table I . After absorption, monospecific antiglobulins had no detectable reaction with nonhomologous myeloma proteins by agar diffusion. Monospecific antiglobulins coupled to bromoacetyl-cellulose (26) did not bind t25I-labeled light chains or myeloma proteins of immunoglobulin classes other than the one against which the antigl0bulin was directed.
Spleen Cell Cultures.--Spleen cell suspensions were prepared under sterile conditions by gently teasing apart the spleens with forceps into cold HBSS; after residual tissue fragments had settled by gravity, the supernatant cell suspension was separated and centrifuged for 10 min at 600 g at 4°C. The sedimented cells were resuspended to the desired density, usually 1 X 107 cells/ml, in completely supplemented Eagle's minimal essential medium (MEM), monolayer type, with Hanks' salts (21, 22, 27) , containing 10% fetal bovine serum (Reheis Chemical Co., Kankakee, II1., Lot E21505), and 50 units each/ml of penicillin and mycostatin, and 50 #g/ml of streptomycin. Tissue culture media and supplements except sera were obtained from Microbiological Associates, Inc., Bethesda, Md.
The spleen cells in 1 ml volumes were incubated with or without erythrocyte antigens, usually 106-107/culture, in a water-saturated atmosphere of 7% 02, 10% CO~, and 83% N2 at 37°C in a large alr-tight plastic box on a rocker platform oscillating at 31~ complete cycles/ rain. Experimental groups were composed of three culture dishes which were supplemented daily with 0.05 ml fetal bovine serum and 0.05 ml of a nutritional mixture prepared by supplementing HBSS with 10 mg/ml dextrose and glutamine and amino acids in twice the concentration as in completely supplemented MEM (22, 27) .
Hemolytic Plaque A ssay.--Cells from each experimental group were harvested by aspiration, pooled and sedimented by centrifugatiou. The supernatant culture fluid was discarded and the sedimented cells were resuspended in HBSS at dilutions expected to give 30-300 plaques/slide. The number of PFC was determined by the Jerne hemolytic plaque technique (6, 7) , modified for use with glass microscope slides (5, 21, 22) and illustrated in Fig. 1 .
For enumeration of direct or "yM PFC, agarose (L'Industrie Biologique Francaise S.A., Gennevilliers, France), 0.5% in tris(hydroxymethyl)aminomethane (Tris)-buffered Eagle's MEM without serum (Medium 327 from the NIH Media Unit), 0.40 ml; indicator erythrocytes, 7.5%, 0.05 ml; and the culture cell suspension, 0.1 ml, were mixed at 44°C in 10 X 75 mm glass tubes and poured onto microscope slides previously coated with 0.1% agarose in water. Duplicate slides, prepared from each group, were incubated for 1 hr at 37°C in a humid atmosphere; HBSS was flooded under the slides and incubation was continued for 1 hr. Guinea pig complement (Baltimore Biological Laboratories, Baltimore, Md.), diluted N0 or 1/50 in 0.85% NaC1 buffered at pH 7.4 with 0.01 M phosphates and containing 5 X 10 -4 Mg ++ and 1.5 X 10 -4 M Ca ++ (28) was added, and incubation was continued for another hour. PFC were counted at 7 X magnification with indirect illumination.
Indirect PFC ('yG and "yA immunoglobulin classes) were enumerated by two new methods in addition to the conventional method for indirect PFC (29, 30) . In the blocked "yM PFC method, 0.05 ml of a predetermined optimal dilution of goat anti-mouse g-chain antibody was added to the assay tubes containing agarose in Tris-MEM and indicator erythrocytes before the addition of the immune cell suspension (Fig. 1) . The mixture was poured on agarose-coated microscope slides. After 1 hr incubation, a predetermined optimal concentration of polyvalent or monospecific rabbit anti-mouse globulin in HBSS was flooded under the slides; incubation was continued for 1 hr, the antiglobulin poured off, and the slides washed once gently with HBSS. Complement was then added and after 1 hr incubation, PFC were counted.
In the sequential PFC devdopment melhod, assay slides containing indicator erythrocytes and immune cells in agarose in Tris-MEM were incubated as described for development of 5'M PFC. Mter these PFC were counted (count 1), antiglobulin at optimal dilution or HBSS was flooded under the slides and incubation was continued as described for development of 3'G PFC in the blocked 7M PFC method. No goat anti-g-antibody was ever added to these preparations. After incubation with complement, total plaques were counted (count 2). Cells recovered from culture dishes were counted with a Coulter Counter, Model B, with a 100 g aperture (Coulter Electronics Inc., Hialeah, Fla.). The "I'M PFC/106 recovered cells were calculated from slides developed only with complement. 3'G and 'yA PFC/106 recovered cells in the blocked 7M PFC assay method were calculated directly from assay slides developed by antiglobulin and complement since the goat anti-g-antibody in the agarose layer prevented development of any 7M PFC. Control slides of indicator erythrocytes, goat antig-antibody, and immune cells in agarose incubated only with complement insured the complete blocking of all 3'M PFC.
In the sequential PFC development method, counts 1 and 2 were converted to PFC/106 recovered cells. The net increase in PFC or indirect PFC/106 recovered cells was calculated by subtraction of PFC/106 cells ( count 1) and additional 3'M PFC/106 cells developed by HBSS and complement from total PFC/106 cells (count 2). Data presented are from experiments with comparable cell recovery in all experimental groups and are representative of data obtained in at least three separate expreriments.
RESULTS

Development o/the Blocked "yM PFC Assay Method.--Previous studies in our
laboratory had not detected significant primary 5'G PFC responses in spleen cell cultures of BALB/c AnN mice using conventional methods of facilitation with several polyvalent antiglobulins (22) . These polyvalent antiglobulins are known to inhibit "yM PFC development; this inhibition must be corrected for in calculation of 7G PFC developed by such antiglobulins (2, 29, 30) . In the present studies, we found that the inhibition of 7M PFC development by polyvalent antiglobulins in cultures containing only "yM PFC varied considerably from experiment to experiment and among mouse strains. The mono-specific antiglobulins also variably inhibited ~,M PFC development, but to a far lesser degree. Mter taking all these variables into account, consistent primary ~,G PFC responses were recently detected in our culture system using the conventional assay procedures and the antiglobulin reagents described herein (31) . However, the result obtained with this method showed considerable variability; therefore, a more reliable method for detection of indirect PFC was developed which does not require application of correction factors to the data.
Anti-TM antibody is known to inhibit development of 73~ PFC (2, 29, 30) . We found that goat anti-/z-chain antisera prepared against MOPC-104E and absorbed with X-light chains reproducibly inhibited development of all "y1Vi PFC when incorporated into the assay reagent mixture at final dilutions of 1/,60o0-1/~600 depending on the antiserum. This inhibition was almost completely reversed by the addition of MOPC-104E myeloma protein at a concentration of 100 #g/ml; other myeloma proteins ('h, ")'2~, ")'2b, and 7A) produced at most 10% reversal at 100/~g/ml. Unrelated proteins, such as bovine serum albumin, had no effect on the blocking of ~,M PFC development even at 1 mg/ml.
The incubation of assay slides containing the anti-#-antibody and immune cells from 5-day cultures with polyvalent or monospecific antiglobulins and complement reproducibly resulted in the development of significant numbers of plaques. The number of'),G or "),A PFC enumerated by the blocked ~?M PFC method was comparable to the number detected by the sequential PFC development method (Table II) ; both these methods compared favorably with the conventional assay method for detection of "yG or "),A PFC. In addition, the number of indirect PFC detected by developing PFC with anti-~,l and anti-~' 2~+2b together was similar to the sum of the number of ")'1 and ~' 2~+2b PFC detected separately (Table II) .
Cultures of spleen cells from BALB/cAnN mice developed lower ~,G PFC responses to both SRBC and HRBC at all ages tested than did cultures of spleen cells from C57BL/6N mice; therefore, C57BL/6N mice were used for the remainder of the experiments reported. Monospecific and polyvalent antiglobulins were absorbed with myeloma proteins as indicated in Table III . Absorption was accomplished by adding sufficient homologous myeloma proteins to precipitate the antibody completely; samples of antiserum with equal amounts of other myeloma proteins added served as controls. The number of plaques developed by these antiglobulins after absorption and removal of precipitates by centrifugation was compared with the number developed by untreated antiglobulin at the same dilution and the per cent of inhibition of plaque development was determined.
Specificity of Plaques Developed by A ntiglobulins in the Blocked
The developing activity of the monospecific antiglobulins (anti-'h, anti-7A, and anti-72~+2b) was removed only by absorption with the homologous myeloma protein(s). The activity of the polyvalent anti-'rG was markedly decreased after absorption with myeloma proteins of the "rG class; about 20% * Numbers in parentheses are the sums of PFC/106 cells from the separate assays with anti-3q and anti-')'2a+2b.
:~ Number of additional "yM PFC appearing after incubation with HBSS and complement have been subtracted from the total increase in PFC/106 ceUs to obtain the net increase due to PFC developed by antiglobulin and complement. reduction in activity was also detected after absorption with "i'M or "yA myeloma proteins (Table III) . Results using both the blocked ~M PFC and sequential PFC development methods were comparable (Table III) . However, a word of caution must be raised with regard to the blocked ~/M PFC method when antiglobulins to which myeloma proteins have been added either for the purpose of absorption or competitive inhibition of activity are used in this assay method. ~M myeloma proteins, or reagents contaminated with 7M protein not detectable by other methods, may cause some reversal of the blocking of "i'M PFC development by the anti-/z-serum. This reversal of blocking of "i'M PFC development was highly reproducible for any antiglobulin to which myeloma proteins had been added. 3'1, 3"2a+2h, and 3"A myeloma proteins caused less than 10% reversal at concentrations of 100 gg/ml. "rM myeloma protein, however, produced almost 95 % reversal at 100 gg/ml, but less than 10% reversal at 10 #g/ml. Therefore, the degree of reversal for each antiglobulin reagent to which myeloma proteins have been added must be determined on an immune cell suspension containing only 3`M PFC (spleen cells * The values represent averages from at least four separate experiments with different C57BL/6N immune cell suspensions from 5-day stimulated cultures using the absorbed antiglobulins at the same dilutions as the control, unabsorbed antiglobulins. The method used for absorption is presented in the text. from a 3 day stimulated culture) on the same day that the reagent is used in assays on cell suspensions containing 3`G or 3'A PFC. Only in this manner can an accurate evaluation of the effects of proteins on the activity of antiglobulin reagents in the blocked 3'M PFC method be made. This correction has been applied to the data obtained with the blocked ~/M PFC method in Table II[. Competitive inhibition of antiglobulin activity with myeloma proteins also demonstrated specificity. Myeloma proteins at a final concentration of 100-0.1 #g/ml were incubated with optimal dilutions of the antiglobulins at 37°C for 1 hr with periodic agitation. The activity of these preparations in developing indirect plaques was compared with untreated antiglobulins and the per cent of inhibition of indirect PFC development for each myeloma protein at each concentration was calculated. Significant inhibition of activity of any antiglobulin was achieved only with the homologous myeloma protein(s) ( Table IV) . Homologous myeloma proteins inhibited facilitation almost completely at concentrations of 10/zg/ml. By contrast, other myeloma proteins produced at most 20 % inhibition at concentrations of 100/zg/ml. Corrections were applied :~ Values in parentheses are averages from three separate experiments using the sequential PFC-development method.
for reversal of blocking of 3'M PFC in all experiments at each concentration of myeloma protein. This was especially important when 3'M myeloma protein was the added protein; the data with the 100 /zg/ml concentration of this myeloma protein were at best an approximation since blocking of 3'M PFC was completely reversed at this concentration. Confirmation of all data in the competitive inhibition test with the 100/zg/ml concentrations was obtained using the sequential PFC development method with immune cell concentrations that gave accurately countable numbers of PFC per slide (Table IV) .
The obvious control of substituting normal rabbit serum, decomplemented and absorbed with SRBC and mouse spleen cells, at the same dilution as the rabbit antiglobulins, should be adequate. However, several "normal rabbit sera" developed indirect PFC. Some of these sera consistently developed as many or more PFC than did optimal dilutions of anti-3,G, anti-~l, or anti-q,2~+2b. This developing activity was not competitively inhibited by 100 ~g/ml of any myeloma protein. Furthermore, the addition of q¢1 or 3'2a+2b myeloma proteins in amounts exceeding that required to absorb activity from specific antiglobulins did not significantly reduce activity in the normal rabbit sera.
Only absorption with antigen-antibody complexes significantly reduced the developing capacity of these sera; activity of the monospecific and polyvalent anti~I'G sera were unaffected by absorption with the same antigen-antibody complexes. Data similar to those obtained with the blocked 3'M PFC method were also obtained with the sequential PFC development method. It is uncertain whether this facilitating activity of some normal rabbit sera is due to a rheumatoid-like factor (32, 33) or some other artifact. This observation has merited a more detailed separate study? It is clear, however, that antiglobulins with nonspecific facilitating activity as found in normal rabbit sera and some unabsorbed polyvalent anti-~/G sera must be sought out and eliminated from routine use. Monospecific and absorbed polyvalent antiglobulins probably lack this abnormal reactivity since during their purification the immune complexes formed in the reaction mixture removed the serum components mediating the nonspecific facilitating activity.
Culture Variables Affecting 3tM, ~G, and "yA PFC Responses.--As indicated above, C57BL/6N mice consistently developed higher PFC responses than BALB/cAnN mice; responsiveness among other inbred mouse strains has not yet been fully investigated. No difference was found in the "I'M, 3'G, and ~,A PFC responses of C57BL/6N males and females. SRBC and HRBC both stimulated adequate 3'M, ~/G, and ~A PFC responses in cultures of C57BL/6N spleen cells. Since adequate numbers of PFC representing all the immunoglobulin classes were detected with the culture conditions described above, modifications of these conditions were not made.
Optimal spleen cell concentration for development of maximal 5-day 3'M, ~'G, and ~A PFC responses was consistently between 15 and 8.5 )< 106 spleen cells/culture dish. In subsequent experiments, the spleen cell concentration was adjusted as closely as possible to 10 )< 106 cells/culture. The plot of the log of the 3'M or TG PFC response per dish against the log of the number of spleen cells initially cultured as the spleen cell concentration was varied from 25 to 0.5 )< 106 cells/dish produced a regression line with a slope approximately 2.5 over the linear portion of the plot. Earlier, a similar analysis of the ~/M response alone produced a regression line with a similar slope; it was suggested that interactions among three cell types were required for development of that response (34) .
Optimal antigen dose for stimulation of maximum "yM PFC responses was about 1 X 107 red blood cells (RBC)/culture; however, maximal3'G PFC responses developed consistently in cultures stimulated with 106 RBC/culture (Table V) , Optimum 3'A responses were also obtained with 106 RBC (data 108  1346  427  1122  347  107  1201  481  1474  351  106  1066  528  1008  475  105  495  275  474  458  0  50  3  171  5   10 s  832  177  1466  273  107  837  191  1946  249  106  665  235  1059  296  105  309  138  640  130  0  29  7  60  8   108  715  220  661  101  107  889  271  859  153  106  686  350  688  373  105  401  121  290  97  0  111  2  30  4 not shown). RBC used within 2 wk after collection stimulated consistently reproducible responses in all immunoglobulin classes; RBC used after 14 days storage stimulated lower and more varied responses and were more fragile in the assay system. Subsequent experiments used RBC less than 14 days old at 3-7 X 10 6 RBC/culture. Maximal 7M and ~G responses developed in cultures of spleens from mice 4-6 months old; however, responses in spleen cell cultures from mice as young as 2 months or as old as 9 months were adequate for the study of cellular events in the development of either'gM or 3'G responses (Table V) . Responses in unstimulated cultures were not consistently increased in elderly mice. The optimal RBC doses for stimulation of maximal ~M and "yG responses did not vary with mouse age. day lag period, the number of 3'M PFC increased exponentially from background levels, about three PFC/10 ~ spleen cells, to about 1000 PFC/10 ~ cells on day 4 in stimulated cultures. On day 5, only a slight decrease from this maximum was detected, but thereafter 3'M PFC decreased steadily (Fig. 2 ). An increase in "y.¥[ PFC against SRBC was detected also in unstimulated cultures; this response reached a maximum on days 4-5 and was always less than l0 % of the response in stimulated cultures. Similar background responses have been regularly detected by other investigators and are most likely due to antigens cross-reactive with SRB C antigens present in fetal bovine serum (21) .
TABLE V Effect of Mouse Age and Antigen Dose on 5-Day Primary ~/M and 3/G PFC Responses In Vitro
Kinetics of Primary
PFC responses of cells representing 7G and ~A immunoglobulin classes pre-sented a definite contrast. No significant increase from background levels of 0.1-0.3 PFC/106 spleen cells was detected during the first 3 days of culture. Thereafter, a rapid exponential increase to maximum numbers on days 5 or 6 was observed for 71, 72~+2b, and 7A PFC responses in stimulated cultures. After day 6, all responses decreased quite sharply; all attempts to date to prolong these responses beyond day 8 have failed. It is significant to note that 71, "Y2~+2b, and 7A PFC increase in numbers in parallel. ~1 and 72a+2b PFC/106 cells were about equal in numbers, whereas 7A PFC were always somewhat lower. The PFC responses developed by polyvalent anfi-TG were representative of the 71 and'h~+2b responses; this antiglobulin reagent is free of nonspecific facilitating activity and has been used in subsequent experiments to conserve valuable monospecific antiglobulins. 7G and 7A PFC also increased in unstimulated cultures, reaching numbers no greater than 10 % of the responses in stimulated cultures. These background responses usually reached maximums on day 6 and declined very sharply by day 7.
At no time during the 7 day incubation of stimulated cultures were~/M PFC of low hemolytic efficiency detected despite use of assay conditions and rabbit anti-TM antiglobulin known to develop indirect 7M PFC against SRBC in vivo (5) and in other immune systems (35, 36) . In the remainder of this communication we will present data comparing the effects of anti-erythrocyte antibody on the 7M and 7G PFC responses to evaluate the role of antigen in the induction of antibody production.
Suppression of Primary "),M and 7G PFC Responses by Anti-SRBC Antibody.
--Previous studies had indicated that antibody suppresses the 7M PFC response in vitro by neutralizing the effective antigenic stimulus at the macrophage-dependent phase of the response (37) . A rabbit antiserum against SRBC was chosen for suppression of immune responses in the present experiments since mouse antibodies produced "false hemolytic plaques" in the assay of indirect PFC.
To investigate the effect of antibody concentration on suppression of the ~,M and 7G PFC responses, spleen cells were incubated with 3 X 106 SRBC and 3 X 10 ~ HRBC, and 0.05 ml of 10-fold dilutions of rabbit anti-SRBC with an initial hemagglutinin titer of 1/~o00. Antibody concentration (Fig. 3) was the reciprocal of the titer in the culture dish. High concentrations of antibody, 4 X 10 ° and 4 X 10 -I, caused marked suppression of both 7M and 7G PFC responses to SRBC, but had no effect on PFC responses to HRBC. As the concentration of antibody was decreased, the degree of suppression decreased. At any given antibody concentration, the degree of suppression of 7G PFC was always greater than the suppression of 7M PFC. Antibody did not suppress the development of background 7M and 7G PFC (Fig. 3) ; this has been verified for all concentrations of antibody used in the present experiments. Similar suppression of ~/M and 7G PFC to HRBC has been obtained with rabbit anti-HRBC; in these experiments the responses to SRBC were unaffected. The observation that responses to HRBC were unaffected by anti-SRBC showed that suppression of the responses to SRBC was specific and not due to toxicity of the antibody for the cultures.
As was shown previously for ~'M responses alone (37) , suppressive activity of the anti-SRBC was also demonstrated with antigen-antibody complexes prepared with large amounts of antibody. complex containing 107 SRBC prepared with an antibody concentration of 4 X 10 -~ were suppressed to almost the same degree as responses in cultures to which antigen and antibody were added separately. Suppressive activity was removed from the rabbit anti-SRBC during preparation of the complexes as demonstrated by reduced suppressive capacity of the supernate from the complexes. HRBC did not remove suppressive activity from the anti-SRBC when substituted for SRBC in the preparation of complexes.
Previous studies indicated that increasing the antigen dose overcame the suppressive effects of antibody, further suggesting that the mechanism by which antibody suppressed immune responses was by neutralization of the effective antigenic stimulus (37, 38) .
At a dose of 105 SRBC, ~M and q,G PFC responses were suppressed to background levels by anti-SRBC (Fig. 4 a) . As the SRBC dose was increased, the degree of suppression of both q,M and ~'G responses decreased; at a dose of l0 s SRBC, suppression of both responses was completely abrogated (Fig. 4 a, 4 b) . Further, it is significant that at all SRBC doses the degree of suppression of the q'G response again was always greater than the suppression of the q,M response (Fig. 4 b) . The greater susceptibility of q,G responses to the suppressive effects of antibody was further demonstrated in experiments where antibody was added at 24-hr intervals after initiation of the cultures (Fig. 5) . q,M P F C responses were almost completely suppressed by antibody added at the initiation of the cultures or 24 hr later. However, antibody added at 48 hr or later had little or no suppressive effect. I n contrast, considerable suppression of ~/G PFC responses was obtained when antibody was added during the first 48 hr of incubation. (40), with antibody did not produce suppression of either the 7M or ~/G PFC responses. As in other experiments with anti-SRBC, the degree of suppression of the "}'G responses was greater than the degree of suppression of the ~,M response. These data confirm our original findings that antibody suppresses the immune response by neutralizing the effective antigenic stimulus at the level of the macrophage. DISCUSSION We have described the development of ~1, ~'2~+2s, and vA as well as ~,M PFC responses in cultures of mouse spleen cells stimulated in vitro with heterologous erythrocytes. A new procedure for detecting indirect (~,G and 7A) PFC makes analysis of these immunoglobulin class-specific responses possible. This new method makes use of the fact that development of direct (~/M) PFC can be completely inhibited by incorporation of appropriate amounts of a suitable anti-IgM specific antibody into the agarose-indicator erythrocyte-assay mixture. The technique offers several advantages over the conventional methods (1, 2, 5, 10, 11, 29, 30) for assaying indirect PFC. First, the indirect PFC can be directly enumerated from the assay slides. In conventional procedures a correction must be made for the frequently observed suppressive effect of facilitating antiglobulins on development of ~/M PFC. Second, responses studied with this method are more reproducible than with conventional procedures. Finally, the new procedure is rapid; it is certainly less cumbersome than the sequential PFC development method which requires two periods of incubation and two separate PFC counts. The number of indirect PFC determined by this latter procedure and the number determined by the new blocked ~,TN[ PFC method were in very close agreement. The sequential PFC development method was extremely useful, however, in confirming the results of the specificity controls.
Absorption and competitive inhibition controls established the specificity of both blocking (anti-k) and facilitating (anti-~/G, anti-~,l, anti-'h~-2b, and anti-~,A) reagents. In general, homologous myeloma proteins were more than 10 times as efficient in blocking a specific antiglobulin activity than were nonhomologous myeloma proteins. The small amount of blocking obtained with heterologous myeloma proteins can be readily explained by the inevitable small contamination of purified myeloma proteins with normal immunoglobulins. The absolute requirement for such specificity controls was demonstrated by the observation that certain normal rabbit sera developed indirect PFC in all assay procedures employed. The facilitating activity of these sera could neither be blocked nor absorbed with myeloma proteins, but was removed only by immune complexes as has been discussed above.
A PFC response specific for each major class of mouse immunoglobulin developed in vitro. Although the antiglobulin specific for 3'2a+2b did not distinguish between these individual immunoglobulins, it has been shown elsewhere (5) that this antiglobulin is only partially blocked by either class of myeloma protein alone. Reagents specific for the "Y8 immunoglobulin class were not available during this study (43) . In general, tissue culture conditions which supported adequate 3'M responses also supported 3'G and ~/A responses in vitro. Concentrations of spleen cells and ages of mice from which the cells were obtained that produced optimum ~M responses also produced optimum 3"G responses. As has been observed for ~M responses (21, 22) , a low level of 3'G response was seen in unstimulated cultures. Finally, both "yM and "yG PFC responses were specifically suppressed by inclusion in the cultures of appropriate amounts of specific anti-erythrocyte antibody. It was shown that this inhibition was the result of neutralization of the effective antigenic stimulus at the macrophage-dependent phase of the response. This has been estabhshed previously in this laboratory (37) and suggested by others (38) only for ~/M responses in vitro, and is consistent with results of the suppressive effects of antibody in vivo (44--46) .
A detailed study of the kinetics of appearance of "yG and "yA PFC showed that'y1, 3% and 3'A PFC appeared 1-2 days later than did 3'M PFC and reached a peak 1 day later. The 3'1 and 72~+2b responses were somewhat greater than 3'A responses, but all responses showed identical kinetics. These differences in rates of appearance of "),M and 3'G PFC are similar to those observed after immunization in vivo (1, 2, 5) .
A greater sensitivity of the 3'G PFC response to antibody was revealed in two ways. First, any given dose of antibody had a proportionally greater effect on the TG than on the "I'M response. Second, the ~G response could be inhibited by antibody added up to 48 hr after stimulation; in the case of the ~/M response, antibody had to be added before 24 hr after stimulation to achieve complete suppression. It has been shown that in the development of the 3'M PFC response, the first 24 hr is the interval during which critical interactions take place among the various types of lymphoid cells, macrophages, and antigen (41) . The finding that 3'G responses are susceptible to suppressive antibody for 48 hr suggests that these responses may require more prolonged interactions among macrophages, antigen, and lymphoid cells for their development (42) . The investigations of these cell interactions in the development of the primary ~G response will be described in a later communication. ~ A small but consistent difference was seen in the present experiments in the erythrocyte doses which stimulated maximum 3'M and "yG responses. Doses of antigen which produced optimum 3'M responses were of an order of magnitude higher than those that produced optimum 3'G responses. With higher erythrocyte doses, ~G responses were suboptimal. At no erythrocyte dose was the 3'G response equal to the 3'M response. Indeed, 3'M responses equal to optimal "yG responses were usually obtained with low doses of antigen (see Table V ). These findings may be related to the greater observed sensitivity of the ~'G PFC responses to anti-erythrocyte antibody added to the cultures as discussed previously. It is known that 3'M antibody may have an enhancing effect on immune response in vivo (46) . It must be remembered, however, that 3'M antibody in vivo is almost all confined to the circulating blood, and in the mouse is catabolized at a very rapid rate (47) . In vitro, a greater accumulation of 3'M antibody in intimate contact with reactive and differentiating cells is to be expected, and it may, in these circumstances, play an important role in the development and regulation of ~'G PFC responses. SUMMARY We have demonstrated for the first time that mouse spleen ceils stimulated in vitro with heterologous erythrocytes developed immunoglobulin classspecific'yM, "h, "Y2~+2b, and 5'A plaque-forming cell (PFC) responses. A modification of the hemolytic plaque technique, the addition of goat anti-mouse #-chain antibody to the assay preparation, specifically prevented development of all "yM PFC and enabled accurate and reproducible enumeration of immunoglobulin class-specific PFC after treatment with appropriate monospecific antiglobulins and complement. Culture conditions, with regard to medium, atmosphere, agitation, and spleen cell densities, were similar to those previously shown to support only "/M PFC responses. Evaluation of the kinetics of appearance of PFC showed that 5'M PFC reached maximum numbers on days 4-5; the magnitude of this response was 3-10 times greater than 71, ~2a+2b, or ~/A PFC which reached maximum numbers on days 5-6. Optimal erythrocyte antigen dose for ~'M PFC responses was 107/culture, whereas a dose of 106 erythrocytes/culture consistently stimulated optimal ~1, "Y2a+2b, or "yA PFC responses. Investigations of the effects of anti-erythrocyte antibody on ~/M and ~/G PFC responses indicated that antibody suppressed these responses by neutralizing the effective antigenic stimulus at the macrophage-dependent phase of the response. At the same antibody concentration, "yG PFC responses were more effectively suppressed than ~M PFC responses. Further, "yG responses could be almost completely suppressed by antibody as long as 48 hr after initiation of cultures, whereas-yM PFC responses could only be completely suppressed during the first 24 hr. These results were discusssed in terms of the role of antigen in the stimulation ~/M and ~/G antibody.
